Table 2

Major serological, clinical, and histological features of antiactin antibody (AAA) positive adults with coeliac disease

Patient No	Age (y) at diagnosis	AEA IgA titre	TGA IgA titre	AAA IgA titre	AAA IgG titre	Liver disease	DVA	Months of AAA negativity^2-150
1	17	1:160	0.290	1:160	Negative	Absent	Moderate	3
2	18	1:1280	0.124	1:40	Negative	Absent	Severe	nd
3	19	>1:1280	0.359	>1:1280	Negative	Absent	Severe	nd
4	20	1:1280	0.231	1:160	Negative	Absent	Severe	nd
5	21	1:640	0.470	Negative	1:40	Absent	Moderate	3
6	21	>1:1280	1.140	1:640	Negative	Absent	Severe	4
7	24	>1:1280	0.757	>1:1280	Negative	Absent	Severe	nd
8	25	1:1280	0.278	1:340	Negative	Absent	Severe	nd
9	25	1:1280	0.404	1:40	Negative	Absent	Severe	nd
10	26	1:1280	0.111	1:160	Negative	Absent	Severe	nd
11	26	>1:1280	0.590	1:160	Negative	Absent	Severe	4
12	26	>1:1280	0.600	1:160	1:160	Absent	Moderate	3
13	27	1:1280	0.127	1:160	Negative	Absent	Severe	nd
14	27	>1:1280	1.001	>1:1280	Negative	CH	Moderate	3
15	28	1:1280	0.145	1:40	Negative	Absent	Severe	nd
16	29	>1:1280	1.145	1:640	Negative	CH	Severe	4
17	30	1:1280	0.188	1:40	Negative	Absent	Severe	nd
18	31	1:1280	0.221	1:160	1:160	Absent	Severe	nd
19	31	1:1280	0.552	1:80	Negative	Absent	Severe	nd
20	32	>1:1280	0.190	1:40	Negative	Absent	Severe	nd
21	33	1:1280	0.185	>1:1280	1:640	Absent	Severe	nd
22	34	>1:1280	0.710	1:640	Negative	CH	Severe	4
23	35	1:1280	0.147	1:80	Negative	Absent	Severe	nd
24	35	1:1280	0.960	1:640	>1:640	Absent	Severe	nd
25	45	>1:1280	0.950	1:640	Negative	CH	Severe	4
26	54	1:1280	0.116	1:40	Negative	Absent	Severe	nd
27	55	1: 320	0.313	1:40	1:40	CH	Severe	4
28	65	1:1280	0.132	1:40	Negative	Absent	Severe	nd